Acuta Capital Partners’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-250,000
Closed -$3.02M 63
2015
Q2
$3.02M Sell
250,000
-216,279
-46% -$2.13M 1.86% 18
2015
Q1
$3.91M Buy
466,279
+3,279
+0.7% +$25.7K 3.29% 9
2014
Q4
$3.54M Buy
+463,000
New +$3.31M 2.39% 9

Other funds holding LMAT

Acuta Capital Partners's LMAT Position: Q3 2015 in Review

Acuta Capital Partners sold out of LeMaitre Vascular (LMAT) in Q3 2015, closing a stake of 250,000 shares — an estimated $3.02M sold.

Acuta Capital Partners first reported a position in LMAT in Q4 2014 and held it in 3 quarters. The position peaked at $3.91M in Q1 2015. 87 funds tracked by Wall St. Rank hold LMAT as of Q3 2015.

  • Acuta Capital Partners reported no remaining LeMaitre Vascular position as of Q3 2015 after selling out during the quarter.
  • Acuta Capital Partners sold 250,000 LeMaitre Vascular shares in Q3 2015, an estimated $3.02M.
  • Acuta Capital Partners first reported a position in LeMaitre Vascular in Q4 2014 and held it in 3 quarters.
  • Acuta Capital Partners's LeMaitre Vascular position peaked at $3.91M in Q1 2015.
  • 87 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2015.

Based on Acuta Capital Partners's 13F filing for Q3 2015, filed 16 Nov 2015.